• CX-4945 (Silmitasertib): Applied CK2 Inhibition in Cancer &

  2026-07-30

  CX-4945 (Silmitasertib) is a precision tool for dissecting CK2-regulated pathways in both cancer and antiviral research. Leveraging recent mechanistic insights, researchers can design robust workflows for apoptosis induction, cell cycle arrest, and targeted disruption of host-virus interactions.

• S Tag Peptide: Practical Guide for Protein Solubility & Dete

  2026-07-30

  S Tag Peptide enables efficient detection and solubility enhancement for recombinant proteins, particularly in workflows requiring anti-S-Tag antibody-based purification. It is not suitable for use in ethanol-based systems or for standalone enzymatic activity. Researchers should use validated protocols and adhere strictly to solubility and storage guidelines to ensure reproducibility.

• Spermine in Ion Channel Modulation and Membrane Fusion Assay

  2026-07-29

  Spermine, a high-purity endogenous polyamine, empowers researchers to precisely interrogate ion channel function and nuclear envelope fusion events. Explore optimized protocols, troubleshooting strategies, and cross-domain applications that uniquely leverage Spermine for both electrophysiology and viral egress research.

• Diclofenac: Non-Selective COX Inhibitor in Organoid Assays

  2026-07-29

  Diclofenac, a high-purity non-selective COX inhibitor from APExBIO, enables robust inflammation and pharmacokinetic research in hiPSC-derived intestinal organoid models. This article delivers actionable workflows, protocol insights, and troubleshooting strategies to help researchers maximize data quality in advanced in vitro cyclooxygenase inhibition assays.

• Angiotensin II in Applied Hypertension and Fibrosis Research

  2026-07-28

  Leverage Angiotensin II (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe) as a versatile tool for dissecting hypertension mechanisms and modeling cardiovascular or renal fibrosis. This article offers actionable protocols, troubleshooting insights, and workflow enhancements grounded in cutting-edge literature.

• hCG Regulates CXCL10 via Histone Methylation in Human Decidu

  2026-07-28

  This study uncovers how human chorionic gonadotropin (hCG) suppresses CXCL10 expression in human decidual stromal cells by inducing H3K27me3 histone methylation at the CXCL10 promoter. These findings reveal a mechanistic link between placental signals and maternal immune adaptation, with implications for immune cell recruitment and pregnancy maintenance.

• Tigecycline in Translational Research: Unlocking MDR Solutio

  2026-07-27

  This thought-leadership article explores how Tigecycline, a first-in-class glycylcycline antibiotic, is redefining research strategies against multidrug-resistant bacteria. By integrating mechanistic insights, recent epidemiological findings, and practical protocol guidance, it provides translational scientists with a roadmap for maximizing efficacy in both experimental and clinical settings. The discussion leverages new data on carbapenemase gene transmission, highlights workflow best practices, and situates APExBIO’s Tigecycline as a keystone tool for advancing reproducibility and innovation.

• Immunoproteasome Inhibition: Next-Gen Tools for Translationa

  2026-07-27

  Explore how ONX-0914 (PR-957), a selective immunoproteasome inhibitor, is reshaping autoimmune and inflammatory disease research through precise cytokine modulation. This article delivers mechanistic insight, benchmarking strategies for translational researchers, and a forward-looking perspective grounded in the latest scientific literature.

• Nano-Granulated Zoledronate Modulates Innate Immunity for En

  2026-07-26

  Chen et al. introduce a nano-granulated zoledronate (Nano-ZD) platform that targets the mevalonate pathway in innate immune cells within lymph nodes, enhancing both vaccine-induced and antitumor immunity. The study elucidates the mechanism by which Nano-ZD disrupts mitochondrial metabolism, identifying a new axis for immunometabolic adjuvant design.

• RIPA Lysis Buffer Strong: Optimized Protein Extraction for A

  2026-07-25

  RIPA Lysis Buffer (Strong, without inhibitors) from APExBIO empowers researchers with robust, customizable protein extraction for demanding applications like Western blotting, immunoprecipitation, and kinase assays. Its strong detergent formulation and flexibility in inhibitor addition make it ideal for precise workflows in animal cell and tissue studies.

• Lanabecestat (AZD3293): Precision BACE1 Modulation in Alzhei

  2026-07-24

  Explore how Lanabecestat (AZD3293) enables nuanced, evidence-based BACE1 inhibition in Alzheimer's disease research. This article delivers advanced insights and protocol guidance grounded in recent findings on synaptic safety and pathway modulation.

• SAF312 as a Selective TRPV1 Antagonist for Ocular Surface Pa

  2026-07-24

  The reference study establishes SAF312 (Libvatrep) as a highly potent, selective, and noncompetitive antagonist of TRPV1, demonstrating safety and efficacy in preclinical ocular models without impairing wound healing. These findings clarify the therapeutic potential of targeted TRPV1 antagonism for ocular surface pain, addressing limitations of current topical treatments.

• MK-0812: Precision CCR2 Blockade for Monocyte Trafficking St

  2026-07-23

  MK-0812 enables rigorous dissection of CCR2-mediated monocyte recruitment in inflammation and liver disease models, with nanomolar potency and robust in vivo validation. This guide details workflow enhancements, troubleshooting strategies, and translational insights—anchored in the latest gut–liver axis research.

• Nutlin-3a: MDM2 Inhibition and the Intersection with Lipid M

  2026-07-23

  Explore how Nutlin-3a, a leading MDM2 inhibitor, not only activates the p53 pathway but also intersects with emerging lipid metabolic mechanisms in cancer research. This article provides a unique, in-depth look at Nutlin-3a's multifaceted utility and practical assay implications, grounded in the latest scientific findings.

• Thiamet G in O-GlcNAcase Inhibition: Precision Tools for O-G

  2026-07-22

  Explore the advanced scientific applications of Thiamet G, a potent O-GlcNAcase inhibitor, in dissecting O-GlcNAcylation and tau phosphorylation pathways. This cornerstone article uniquely bridges mechanistic depth with emerging assay strategies, setting it apart from prior content.

458 records 10/31 page Previous Next First page 上5页 678910 下5页 Last page